Search results
Next generation of biotechnologists can leverage the power of antibodies to drive significant...
The Times of India· 17 hours agoIn the ever-evolving field of biotechnology, antibody engineering is a field brimming with...
Alumis cuts IPO size, but nets $250M for immune drug work
BioPharma Dive· 7 days agoAlumis’ public offering comes during an uptick in interest in immune drugs. Still, the company sold...